The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease

The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease

Item
http://www.wikidata.org/entity/Q26864937
β3-Adrenoceptor-mediated relaxation of rat and human urinary bladder: roles of BKCa channels and Rho kinaseProfile of a fixed-dose combination of tiotropium/olodaterol and its potential in the treatment of COPD.Cost-effectiveness and budget impact of the fixed-dose dual bronchodilator combination tiotropium-olodaterol for patients with COPD in the Netherlands.Bronchodilators, receptors and cross-talk: Together is better?Double bronchodilation in chronic obstructive pulmonary disease: a crude analysis from a systematic reviewInvolvement of Ca2+ Signaling in the Synergistic Effects between Muscarinic Receptor Antagonists and β₂-Adrenoceptor Agonists in Airway Smooth Muscle.Drugs Interfering with Muscarinic Acetylcholine Receptors and Their Effects on Place Navigation.Structure-Based Design and Discovery of New M2 Receptor Agonists.Inhaled therapies in patients with moderate COPD in clinical practice: current thinking.Hydrostatic pressure and muscarinic receptors are involved in the release of inflammatory cytokines in human bladder smooth muscle cells.Selective inhibition of histamine-evoked Ca2+ signals by compartmentalized cAMP in human bronchial airway smooth muscle cells.Involvement of Allosteric Effect and K Channels in Crosstalk between β₂-Adrenergic and Muscarinic M₂ Receptors in Airway Smooth Muscle
P2860

The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease

Item
http://www.wikidata.org/entity/Q26864937
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
The pharmacological rationale ...... of airway and bladder disease
@ast
The pharmacological rationale ...... of airway and bladder disease
@en
The pharmacological rationale ...... of airway and bladder disease
@nl
type
label
The pharmacological rationale ...... of airway and bladder disease
@ast
The pharmacological rationale ...... of airway and bladder disease
@en
The pharmacological rationale ...... of airway and bladder disease
@nl
prefLabel
The pharmacological rationale ...... of airway and bladder disease
@ast
The pharmacological rationale ...... of airway and bladder disease
@en
The pharmacological rationale ...... of airway and bladder disease
@nl
P1433
P1476
P2093
P275
P2860
P304
P31
P3181
P356
P407
P478
P50
P5008
P577
P5875
P698
P921
P932
P3181
P356
P1433
P1476
The pharmacological rationale ...... of airway and bladder disease
@en
P2093
P275
P2860
P304
P31
P3181
P356
10.1016/J.COPH.2014.03.003
P407
P478
P50
P5008
P577
P5875
P698
P921
P932